Brief: Anges expects to apply for approval to manufacture treatment for severe blockage of the arteries in the legs - nikkei
09/06/2017 20:42
June 9 (Reuters) - Anges Mg Inc 4563.T
* Anges expects to apply in October for approval to
manufacture and market treatment for severe blockage of the
arteries in the legs - Nikkei
Further company coverage: 4563.T
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on AnGes
See all newsTable: Anges -Q1 group results
Brief: Vasomune Therapeutics, Inc., And Anges, Inc., Announce Us FDA Clearance Of Investigational New Drug (Ind) Application For Pegevongitide (Av-001) Treatment In Resuscitation Of Severely Burned Patients
Table: Anges -2025 parent results
Table: Anges -2025 group results
Brief: Anges & Vasomune Therapeutics Enter Agreement For AV-001